{"id":3036,"date":"2019-10-10T04:53:16","date_gmt":"2019-10-10T02:53:16","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=3036"},"modified":"2024-11-21T11:24:40","modified_gmt":"2024-11-21T10:24:40","slug":"difficult-to-treat-infections-and-antimicrobians-use","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/translational-medicine-area\/infectious-disease-and-transplantation-program\/difficult-to-treat-infections-and-antimicrobians-use\/","title":{"rendered":"Difficult to Treat Infections and Antimicrobians Use"},"content":{"rendered":"\n

\n\t\tDifficult to treat infections and antimicrobians use\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

The Difficult to Treat Infections and Antimicrobians Use research group covers a diverse series of lines of clinical and experimental research, all of which have proved to be difficult in terms of finding an effective treatment and optimal use of antimicrobial medicinal products. In all cases, the study aim is to optimise antimicrobial medications, their mechanisms of action and their ability to reach the pathogenic organisms.<\/p>\n

632<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"lo\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tCNS infections
\nMulti-resistant (MR)\u00a0P. aeruginosa\u00a0<\/i>infections
\nOsteoarthritis and osteoarticular implant-associated infections\n\t\t\t\t\tSelected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t